These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Classification of Amyloidosis by Model-Assisted Mass Spectrometry-Based Proteomics. Palstrøm NB; Rojek AM; Møller HEH; Hansen CT; Matthiesen R; Rasmussen LM; Abildgaard N; Beck HC Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008745 [TBL] [Abstract][Full Text] [Related]
26. [Classification of amyloidosis by laser micro-dissection and mass spectrometry based proteomic analysis]. Shen K; Sun W; Sun J; Sun W; Zhong D; Cao X; Zhou D; Li J Zhonghua Xue Ye Xue Za Zhi; 2015 Feb; 36(2):99-102. PubMed ID: 25778882 [TBL] [Abstract][Full Text] [Related]
27. Amyloid Typing by Mass Spectrometry in Clinical Practice: a Comprehensive Review of 16,175 Samples. Dasari S; Theis JD; Vrana JA; Rech KL; Dao LN; Howard MT; Dispenzieri A; Gertz MA; Hasadsri L; Highsmith WE; Kurtin PJ; McPhail ED Mayo Clin Proc; 2020 Sep; 95(9):1852-1864. PubMed ID: 32861330 [TBL] [Abstract][Full Text] [Related]
28. [New advances in the subtyping of systemic amyloidosis]. Sun WY; Li J Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):259-62. PubMed ID: 24598691 [TBL] [Abstract][Full Text] [Related]
29. Laser microdissection and mass spectrometry-based proteomics aids the diagnosis and typing of renal amyloidosis. Sethi S; Vrana JA; Theis JD; Leung N; Sethi A; Nasr SH; Fervenza FC; Cornell LD; Fidler ME; Dogan A Kidney Int; 2012 Jul; 82(2):226-34. PubMed ID: 22495291 [TBL] [Abstract][Full Text] [Related]
30. Twists and turns of determining amyloid type and amyloid-related organ damage: discordance and clinical skepticism in the era of proteomic typing. Kaul E; Pilichowska M; Vullaganti M; Madan N; Comenzo RL Amyloid; 2014 Mar; 21(1):62-5. PubMed ID: 24256111 [TBL] [Abstract][Full Text] [Related]
31. Imaging mass spectrometry analysis of renal amyloidosis biopsies reveals protein co-localization with amyloid deposits. Casadonte R; Kriegsmann M; Deininger SO; Amann K; Paape R; Belau E; Suckau D; Fuchser J; Beckmann J; Becker M; Kriegsmann J Anal Bioanal Chem; 2015 Jul; 407(18):5323-31. PubMed ID: 25935672 [TBL] [Abstract][Full Text] [Related]
32. Amyloidosis of the Lung. Khoor A; Colby TV Arch Pathol Lab Med; 2017 Feb; 141(2):247-254. PubMed ID: 28134587 [TBL] [Abstract][Full Text] [Related]
33. How to diagnose amyloidosis. Mollee P; Renaut P; Gottlieb D; Goodman H Intern Med J; 2014 Jan; 44(1):7-17. PubMed ID: 24024789 [TBL] [Abstract][Full Text] [Related]
35. Biochemical markers in early diagnosis and management of systemic amyloidoses. Lavatelli F; Albertini R; Di Fonzo A; Palladini G; Merlini G Clin Chem Lab Med; 2014 Nov; 52(11):1517-31. PubMed ID: 24870609 [TBL] [Abstract][Full Text] [Related]
36. [Proteomics, a new tool for an accurate typing of amyloidosis]. Colombat M; Holifanjaniaina S; Onifarasoaniaina S; Valleix S; Maisonneuve H; Kahn JE; Rev Med Interne; 2015 May; 36(5):346-51. PubMed ID: 25544147 [TBL] [Abstract][Full Text] [Related]
37. Renal Amyloidosis. Mohamed N; Nasr SH Surg Pathol Clin; 2014 Sep; 7(3):409-25. PubMed ID: 26837447 [TBL] [Abstract][Full Text] [Related]
38. Proteomics and mass spectrometry in the diagnosis of renal amyloidosis. Picken MM Clin Kidney J; 2015 Dec; 8(6):665-72. PubMed ID: 26613021 [TBL] [Abstract][Full Text] [Related]
39. Shotgun protein profile of human adipose tissue and its changes in relation to systemic amyloidoses. Brambilla F; Lavatelli F; Di Silvestre D; Valentini V; Palladini G; Merlini G; Mauri P J Proteome Res; 2013 Dec; 12(12):5642-55. PubMed ID: 24083510 [TBL] [Abstract][Full Text] [Related]